drugset / Trial / NCT01821677

A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema.

NCT01821677

Phase 2 Completed 354 enrolled Ampio Pharmaceuticals. Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the efficacy of ultra low dose danazol (Optina™) for the treatment of diabetic macular edema.

Timeline

Start
2013-02-26
Primary completion
2014-10-30
Completion
2015-01-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Danazol Other / unclassified 0.5 unknown Oral
Subject Danazol Other / unclassified 1 unknown Oral